Àü±¹´ëÇÐ Áý°è°á°ú, »óÀ§ 10À§±Ç³» 5°³ Æ÷Áø
¿ì¸®³ª¶ó 4³âÁ¦ ´ëÇÐÀÇ Æò±Õ Ãë¾÷·ü(Á¤±ÔÁ÷)Àº 49.2%ÀÎ ¹Ý¸é ÀǾà°è¿ Á¹¾÷ÀÚÀÇ Ãë¾÷·üÀº 90%¸¦ ³Ñ¾î¼, »ç½Ç»ó ÀÇ¡¤¾à´ë»ý¿¡°Ô Ãë¾÷´ë¶õÀº µý³ª¶ó À̾߱Ⱑ µÅ ¹ö·È´Ù.
À̰°Àº °á°ú´Â 25ÀÏ ±³À°ÀÎÀûÀÚ¿øºÎ¿Í Çѱ¹±³À°°³¹ß¿øÀÌ °ø°³ÇÑ 2006³âµµ °íµî±³À°±â°ü Á¹¾÷ÀÚ Ãë¾÷ÇöȲÀ» ÅëÇØ ¹àÇôÁ³´Ù.
¸ÕÀú °¢ Àü°øº° Ãë¾÷·ü »óÀ§ 10À§±Ç À̳»¿¡ ÀǾຸ°Ç °è¿Çаú°¡ 5°³³ª Æ÷ÁøÇß´Ù.
°¡Àå Ãë¾÷ÀÌ ÀߵǴ Àü°øÀº ÀÇÇаú·Î Ãë¾÷·ü 95.2%¸¦ ±â·ÏÇß°í ÀÌ¾î °£È£Çаú°¡ 94.7%¸¦ ³ªÅ¸³Â´Ù.
3À§´Â ÃʵÀ°Çаú·Î Ãë¾÷·ü 91.4%¸¦ º¸¿´°í ÇÑÀÇÇÐ 89.9%, Ä¡ÀÇÇÐ 89.9%, ¾àÇÐ 88.7%¸¦ ±â·ÏÇß´Ù.
X
AD
·Î°ÔÀÎÆû ¸ð¸àÅ͸®
À̺¥Æ®Âü¿© ¡æ
ÀǾà°è¿ Çаú´Â 'Àü°øÀÏÄ¡µµ'µµ 100%¿¡ À°¹ÚÇß´Ù. °¢ Àü°øº° ÀÏÄ¡µµ¸¦ º¸¸é Ä¡ÀÇÇÐÀÌ 100%¸¦ ±â·ÏÇß´Ù. ÀÌ´Â Ä¡´ëÁ¹¾÷ÀÚ ¸ðµÎ Ä¡°ú°ü·Ã ¾÷¹«¿¡ Á¾»çÇÑ´Ù´Â ¾ê±â´Ù.
À̾î ÀÇÇÐ 99.9%, ÇÑÀÇÇÐ 99.6%, °£È£ÇÐ 98.8%, ¾àÇÐ 96.6%ÀÇ Àü°øÀÏÄ¡µµ¸¦ º¸¿´´Ù.
ÇÑÆí Àü¹®´ëÇп¡¼ Ãë¾÷ÀÌ Àß µÇ´Â ºÐ¾ß´Â ÇØ¾ç, ºäƼ¾ÆÆ®, ±¤Çп¡³ÊÁö, Ư¼ö±³À°, À¯¾Æ±³À°ÀÇ ¼øÀ̾ú´Ù.
4³âÁ¦ ´ëÇÐ °¡¿îµ¥ Á¹¾÷»ýÀÌ 3,000¸íÀÌ ³Ñ´Â ´ëÇÐÀÇ Á¤±ÔÁ÷ Ãë¾÷·üÀ» º¸¸é, °í·Á´ë°¡ 76.9%·Î °¡Àå ³ô¾Ò°í, ¿¬¼¼´ë(74.1%), ¼º±Õ°ü´ë(68.9%), ÇѾç´ë(64.9%), °Ç±¹´ë(62.6%)°¡ µÚ¸¦ À̾ú´Ù. ¼¿ï´ëÀÇ Á¤±ÔÁ÷ Ãë¾÷·üÀº 51.6%·Î 11À§¿¡ ±×ÃÆ´Ù.
°½Å±¹ ±âÀÚ(ksk@dailypharm.com)